Company intelligence / Profile preview

InfraScan

Philadelphia, Pennsylvania, United Statesinfrascanner.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

The Infrascanner device has been FDA-cleared for use in both adult and pediatric populations to aid rapid detection of traumatic intracranial hematomas. Clinical studies have demonstrated its effectiveness compared to CT scans for initial triage. Over 1,000 devices are deployed globally.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (hand-held near-infrared brain scanner)
Industry: Medical Imaging

Partnerships

U.S. Army Medical Materiel Development Activity[5]U.S. Marine Corps[5]Office of Naval Research[1][5]

Beyond the preview

Go deeper on InfraScan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InfraScan.

Explore the full profile